Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Romy E Van Weelderen, Kim Klein, Meyrina D Natawidjaja, Ralph De Vries & Gertjan JL Kaspers. (2021) Outcome of pediatric acute myeloid leukemia (AML) in low- and middle-income countries: a systematic review of the literature. Expert Review of Anticancer Therapy 21:7, pages 765-780.
Read now
Read now
Ketan P. Kulkarni & Ram K. Marwaha. (2012) Outcome of T Cell and Other High Risk Subtypes of Acute Lymphoblastic Leukemia in India: An Under-reported Entity. Pediatric Hematology and Oncology 29:6, pages 565-567.
Read now
Read now
Ketan Prasad Kulkarni & Ram Kumar Marwaha. (2012) Need of Assessment of Outcomes in Cancer-Treating Centers: Specific Challenges in the Management of Pediatric Acute Leukemia in India. Pediatric Hematology and Oncology 29:2, pages 195-196.
Read now
Read now
Satya Prakash Yadav, Mohammed Ramzan, Meena Lall & Anupam Sachdeva. (2011) Pediatric Acute Myeloid Leukemia: Final Frontier for Pediatric Oncologists in Developing World. Pediatric Hematology and Oncology 28:8, pages 647-648.
Read now
Read now
Articles from other publishers (13)
Venkatraman Radhakrishnan, Sameer Bakhshi, Smita Kayal, Cherian Thampy, Ankit Batra, Praveen Kumar Shenoy, Hemanth Kumar, Swaminathan Rajaraman, Shilpi Chaudhary, Reema Bisht, Biswajit Dubashi & Trivadi S. Ganesan. (2022) Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial. Blood Cancer Journal 12:9.
Crossref
Crossref
Shyam Srinivasan, Venkata Rama Mohan Gollamudi & Nidhi Dhariwal. (2022) Pediatric Acute Myeloid Leukemia in India: A Systematic Review. Indian Journal of Medical and Paediatric Oncology 43:04, pages 342-348.
Crossref
Crossref
Liang Wang, Chun Li, Fang Xu, Fang Cao, Bo Zhang, Jing Wang, Shen Wang, Li Chen, Na Li, Chenglin Liao & Hongjun Liu. (2021) Analysis of efficacy, safety and prognostic factors of DAC‑HAA treatment in Chinese pediatric patients with refractory or relapsed acute myeloid leukemia. Molecular and Clinical Oncology 15:6.
Crossref
Crossref
Shalabh Arora, Deepam Pushpam, Akash Tiwari, Priyanshu Choudhary, Anita Chopra, Ritu Gupta, Rajive Kumar & Sameer Bakhshi. (2020) Allogeneic hematopoietic stem cell transplant in pediatric acute myeloid leukemia: Lessons learnt from a tertiary care center in India. Pediatric Transplantation 25:3.
Crossref
Crossref
Yixin Hu, Aili Chen, Li Gao, Hailong HeShuting Jiang, Xinchang Zheng, Peifang XiaoJun LuYi WangJie LiJianqin LiJunjie FanYanhua YaoJing LingLiyan FanShengqin ChengCheng ChengFang FangJian PanQian-fei Wang, Raul C. Ribeiro & Shaoyan Hu. (2021) Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study. Blood Advances 5:7, pages 1837-1847.
Crossref
Crossref
Rajan Kapoor, Karthik Ram Mohan, Shuvendu Roy, Suman Kumar Pramanik, Sanjeev Khera & A K Simalti. (2021) Treating acute myeloid leukemia among children with down syndrome. Indian Journal of Medical and Paediatric Oncology 41:06, pages 841-845.
Crossref
Crossref
Deepak Bansal, Alan Davidson, Eddy Supriyadi, Festus Njuguna, Raul C. Ribeiro & Gertjan J. L. Kaspers. (2019) SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource‐limited settings. Pediatric Blood & Cancer.
Crossref
Crossref
Sudha Sinha, Gustav Brattström, Gayatri Palat, Vineela Rapelli, Mikael Segerlantz, Eva Brun & Thomas Wiebe. (2021) Treatment Adherence and Abandonment in Acute Myeloid Leukemia in Pediatric Patients at a Low-Resource Cancer Center in India. Indian Journal of Medical and Paediatric Oncology 40:04, pages 501-506.
Crossref
Crossref
Gaurav Narula, Maya Prasad, Shalini Jatia, PapagudiG Subramanian, Nikhil Patkar, Prashant Tembhare, Dhanlaxmi Shetty, Nehal Khanna, Siddharth Laskar, Tanuja Shet, Sridhar Epari, Seema Kembhavi, Sneha Shah, Sajid Qureshi, Sumeet Gujral & ShripadD Banavali. (2017) Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital. Indian Journal of Cancer 54:4, pages 609.
Crossref
Crossref
Wasil Jastaniah, Ibrahim Al Ghemlas, Saad Al Daama, Walid Ballourah, Mohammad Bayoumy, Faisal Al-Anzi, Omar Al Shareef, Abdulrahman Alsultan, Mohammed Burhan Abrar & Reem Al Sudairy. (2016) Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study. Leukemia Research 49, pages 66-72.
Crossref
Crossref
Venkatraman Radhakrishnan, Cherian Thampy, Prasanth Ganesan, Rejiv Rajendranath, Trivadi S. Ganesan, K. R. Rajalekshmy & Tenali Gnana Sagar. (2015) Acute Myeloid Leukemia in Children: Experience from Tertiary Cancer Centre in India. Indian Journal of Hematology and Blood Transfusion 32:3, pages 257-261.
Crossref
Crossref
Dan Hong, Chenyan Zhou, Hailong He, Yi Wang, Jun Lu & Shaoyan Hu. (2016) A 10-Year Follow-up Survey of Treatment Abandonment of Children With Acute Myeloid Leukemia in Suzhou, China. Journal of Pediatric Hematology/Oncology 38:6, pages 437-442.
Crossref
Crossref
Oneal Gupta, Roopak Aggarwal & Rajni Prasad. (2011) Acute Myeloid Leukemia (AML-M2) with Translocation (8;21) (q22;q22) and Abnormal Eosinophilic Precursors in the Bone Marrow—A Case Report. The Indian Journal of Pediatrics 79:2, pages 256-259.
Crossref
Crossref